Furthermore, while the study showed that serum BNP could be measured to monitor the response to HF treatment and improvements in NYHA functional capacity, the study did not explore the relationship between BNP-guided treatment response and hard outcomes such as mortality. The gene discussed is NPPB; the disease is hydrops fetalis.